Swisher takes over Sanolite
With this acquisition, Swisher Hygiene will use Sanolite’s headquarters to operate its chemical business in the Northeast region. The new regional operating structure allows for more efficient distribution
HAYA Therapeutics has secured fast track designation from the US Food and Drug Administration (FDA) for its investigational therapy, HTX-001, to treat symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM).